Market-Moving Exclusives Archives - Page 8 of 22

1 minute read

EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody

December 5, 8:45 AM

Ocean Biomedical (NASDAQ: OCEA) announced that its Scientific Co-founder, Jack Elias, co-authored new findings in the peer-reviewed journal Immunity that detail the mechanisms behind the role of chitinase 3-like-1 (CHI3L1) in the growth of triple-negative breast cancer.

OCEA

2 minute read

Joe Biden Chokes China’s EV Industry, Proposes Fresh Regulations To Reshore Auto Supply Chain: How To Invest In The Initiative

By Melanie Schaffer

December 4, 1:08 PM

The Tema ETF Trust Tema American Reshoring ETF (ARCA: RSHO) was consolidating Monday after surging 2.34% on Friday. The move higher came after President Joe Biden proposed fresh regulations aimed at boosting the production of electric vehicle batteries and their components in the United States.

RSHO

2 minute read

Spotify Stock Up 10% On Layoff News, Golden Cross Indicates Rally Could Extend Further

By Surbhi Jain

December 4, 1:05 PM

On a year-to-date basis, Spotify stock has returned over 120% to its investors. We'll look at the reasons behind the recent rally.

SPOT

1 minute read

Dow’s New All-Time-High: DIA Outperforms SPY In November — This Component Stock Is Up Over 90% YTD

By Surbhi Jain

December 4, 11:25 AM

The Dow Jones Industrial Average Index hit a new ATH of 36,264.85. DIA ETF overtakes SPY ETF over the past 5 days and the month.

AAPL

2 minute read

S&P 500 Recorded Its 2nd Best November Since 1980: Strategists See Bullish 6 Months Ahead

By Surbhi Jain

December 4, 9:57 AM

November 2023 saw the S&P 500 index rallying 8.9%. ETFs tracking the index also rallied, sparking optimism in the markets for bullish 6 months ahead.

IVV

1 minute read

EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia

By Vandana Singh

November 29, 8:00 AM

SAB Biotherapeutics Inc (NASDAQ: SABS) announced that the first HUMAN trial participants (Fully HUman anti-thymocyte biologic in a first-in-MAN clinical study) have been dosed in Australia.

SABS

2 minute read

SEC Urged To Investigate Elon Musk, Neuralink Over Animal Testing, Securities Fraud

By Surbhi Jain

November 22, 1:38 PM

Four U.S. lawmakers have requested SEC to investigate Elon Musk over Neuralink's misleading safety claims.

TSLA

1 minute read

EXCLUSIVE: Janover’s Q3 Shows Strong Sales Growth but Increased Net Loss, Focuses on AI and Strategic Partnerships

By Anusuya Lahiri

November 14, 9:15 AM

Janover Inc (NASDAQ: JNVR) announced its financial results for the third quarter ended September 30, 2023. Revenue for the quarter ended September 30, 2023, was $583,785, an increase of 11% year-on-year. Revenue per transaction increased 78% Y/Y.

JNVR

1 minute read

EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise’s Subsidiary Highlights Approach to Biological Sequence Retrieval

By Vandana Singh

November 13, 9:01 AM

ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary BioStrand has published a preprint of its white paper titled "New Paradigm for Biological Sequence Retrieval Inspired by Natural

IPA

1 minute read

EXCLUSIVE: AI-Based Ad Solution Firm Inuvo Reports Positive Q3 Free Cash Flow And Adjusted EBITDA, Sales Jump 44%

By Vandana Singh

November 10, 9:15 AM

Inuvo Inc (NYSE: INUV) has reported Q3 net revenue of $24.6 million, compared to $17.1 million for the same period last year, beating the

INUV